Heron Therapeutics, Inc. (HRTX) — Dilution Risk Analysis
Current Snapshot
Heron Therapeutics, Inc. (HRTX) has a DilutionWatch score of 57/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 57/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: XBRL 1, 4 9.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-4975-xbrl_convertible |
| 4 | 2026-04-06 | 0001193125-26-144196 |
| 4 | 2026-02-03 | 0001193125-26-034490 |
| 4 | 2026-02-03 | 0001193125-26-034491 |
| 4 | 2026-02-03 | 0001193125-26-034492 |
| 4 | 2026-02-03 | 0000921895-26-000200 |
| 4 | 2026-02-03 | 0001193125-26-034625 |
| 4 | 2026-02-03 | 0001193125-26-034626 |
| 4 | 2026-02-03 | 0001193125-26-034627 |
| 4 | 2026-02-03 | 0001193125-26-034628 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 5 months | Source |
| Three-year share count growth | 26.51% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 57/10) Source
- Cash Runway
- 5 months Source
- Share Count Growth (3-Year)
- 26.51% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.